slide deck (pdf) - CME Outfitters

More documents

Recommendations

Info

International Prostate Symptom Score (I-PSS) Questionnaire McVary KT, et al. J Urol. 2011;185(5):1793-1803. PMID: 21420124. Available at http://www.urospec.com/uro/Forms/ipss.<strong>pdf</strong>
The Purpose of the Voiding Diary ! Identifies voiding frequency and volumes ! Differentiates behavioral problems as opposed to ones of pathologic origin ! Voiding frequently after drinking the 40 ounce cola at lunch or break (behavioral) ! Voiding frequently of small amounts only at work as a result of always being in a rush (behavioral) ! Voiding frequently of small amounts (OAB) ! Voiding frequently of large amounts (overproduction of fluid – medical cause or excessive intake) ! Alerts the patients as to their habits and may offer opportunities for improvement ! Can help monitor efficacy of treatment Wyman JF, et al. Int J Clin Pract. 2009; 63(8):1177-1191. PMID: 19575724.
Page 1 and 2: Gaining Ground in Men’s Genitouri
Page 3 and 4: Accreditation This program has been
Page 5 and 6: Learning Objectives ! Explain the s
Page 7 and 8: Matt T. Rosenberg, MD Disclosures S
Page 9 and 10: Disclosures ! Faculty of this CE ac
Page 11 and 12: Get Social with Us CMEOutfitters.co
Page 13 and 14: Georgia Association of Physician As
Page 15 and 16: Matt T. Rosenberg, MD Disclosures S
Page 17 and 18: In what percentage of your patients
Page 19 and 20: Function of the Prostate Normal Fun
Page 21 and 22: Benign Prostatic Hyperplasia ! A co
Page 23 and 24: Predominant Symptoms ! The enlarged
Page 25 and 26: Definition of OAB International Con
Page 27 and 28: How to differentiate the etiology o
Page 29 and 30: Common Comorbidities in BPH-LUTS Co
Page 31 and 32: Audience Response Question Fact: ED
Page 33 and 34: BPH-LUTS and ED Common Pathophysiol
Page 35 and 36: What to Keep in Mind in the Evaluat
Page 37 and 38: The Evaluation of LUTS: History, Ph
Page 39 and 40: Medications Can Cause or Exacerbate
Page 41 and 42: Laboratory Tests ! Urinalysis ! Inf
Page 43: Audience Response Question The most
Page 47 and 48: Rosenberg MT, et al. Publication Pe
Page 49 and 50: STEP 1: Informed Surveillance If th
Page 51 and 52: Clinical Management Step2a: Alpha B
Page 53 and 54: Clinical Management Step2b: Phospho
Page 57 and 58: Antimuscarinics - Immediate Release
Page 59 and 60: ! Dry Mouth ! Constipation ! Headac
Page 61 and 62: Beta 3 Agonists Drug Mirabegron Dos
Page 63 and 64: Clinical Management Step3b: Adding
Page 65 and 66: 5 Alpha Reductase Inhibitors (5ARI)
Page 69 and 70: Clinical Connections: Summary ! Tre

slide deck (pdf) - CME Outfitters

Create successful ePaper yourself

Delete template?

Save as template?